Novo Nordisk A S annual dividends paid
2019
2020
2021
2022
2023
2024
2025
Novo Nordisk A S Dividends Paid Growth & History (NVO)
Novo Nordisk A S paid kr51.76B in dividends during fiscal 2025.
View full Novo Nordisk A S company overviewNovo Nordisk A S annual dividends paid history
| Fiscal year | Period ended | Dividends paid | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | kr51.76B | kr7.62B | +17.27% |
| 2024 | 2024-12-31 | kr44.14B | kr12.37B | +38.95% |
| 2023 | 2023-12-31 | kr31.77B | kr6.46B | +25.55% |
| 2022 | 2022-12-31 | kr25.30B | kr3.79B | +17.60% |
| 2021 | 2021-12-31 | kr21.52B | kr1.40B | +6.94% |
| 2020 | 2020-12-31 | kr20.12B | kr712.0M | +3.67% |
| 2019 | 2019-12-31 | kr19.41B | — | — |
Novo Nordisk A S dividends paid trends
Over the last five fiscal years, Novo Nordisk A S's dividends paid increased from kr20.12B to kr51.76B, a change of kr31.64B.
About the metric
What dividends paid mean
Dividends paid are cash distributions made to shareholders. The history shows the company’s aggregate cash outflow for dividends, not the dividend per share, dividend yield, or the date an investor receives a payment.
Calculation and source
Reported cash dividends paid
TickerStat standardizes cash dividends paid to common or ordinary shareholders from official cash-flow filings. Reported zero-dividend periods remain zero and are not treated as missing data. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Novo Nordisk A S source filings ↗Community posts
Novo Nordisk reports positive STEP Young results in children aged 6 to under 12
Novo Nordisk announced first STEP Young Phase 3 results on 7 September 2026. Trial design and outcome The randomised, double-blind study involved 165 children aged 6 to under 12, comparing weekly semaglutide with placebo. Both groups receiv ...